Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Surrozen, Inc. before investing.

In this article, we go over a few key elements for understanding Surrozen, Inc.’s stock price such as:

• Surrozen, Inc.’s current stock price and volume
• Why Surrozen, Inc.’s stock price changed recently
• Upgrades and downgrades for SRZN from analysts
• SRZN’s stock price momentum as measured by its relative strength

About Surrozen, Inc. (SRZN)

Before we jump into Surrozen, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Want to learn more about Surrozen, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Surrozen, Inc..

Surrozen, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Surrozen, Inc.’s stock price was $22.210.

Surrozen, Inc. is up 6.63% from its previous closing price of $20.830.

During the last market session, Surrozen, Inc.’s stock traded between $20.750 and $22.580. Currently, there are approximately 10.95 million shares outstanding for Surrozen, Inc..

Surrozen, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Surrozen, Inc. Stock Price History

Surrozen, Inc.’s (SRZN) price is currently down 14.41% so far this month.

During the month of July, Surrozen, Inc.’s stock price has reached a high of $26.820 and a low of $18.120.

Over the last year, Surrozen, Inc. has hit prices as high as $35.000 and as low as $9.030. Year to date, Surrozen, Inc.’s stock is down 1.73%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Surrozen, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Surrozen, Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Surrozen, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Surrozen, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Surrozen, Inc. (SRZN) by visiting AAII Stock Evaluator.

Relative Price Strength of Surrozen, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Surrozen, Inc. has a weighted four-quarter relative price strength of 11.95%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how Surrozen, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Surrozen, Inc. Stock Price: Bottom Line

As of July 31, 2026, Surrozen, Inc.’s stock price is $22.210, which is up 6.63% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Surrozen, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.